<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00391703</url>
  </required_header>
  <id_info>
    <org_study_id>DCIC05/31</org_study_id>
    <nct_id>NCT00391703</nct_id>
  </id_info>
  <brief_title>Assessment of Quadriceps Muscle Electrostimulation Used in Patients Suffering From Cystic Fibrosis</brief_title>
  <acronym>STIMUCO</acronym>
  <official_title>Assessment of Quadriceps Muscle Electrostimulation Used as an Additional Procedure for Effort Retraining in Patients Suffering From Cystic Fibrosis Associated With Severe Pulmonary Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Vaincre la Mucoviscidose</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an add-on, randomized, open label, clinical trial that evaluates the use of
      quadriceps electrostimulation as an additional retraining procedure in patients suffering
      from cystic fibrosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cystic fibrosis is an autosomal recessive genetic disease due to a mutation of the CFTR
      protein gene. The CFTR protein transports chloride ions (Cl-) across cell membranes in the
      lungs, pancreas, digestive tract, reproductive tract, and skin.

      CFTR mutation mainly leads to a dysfunction of the pulmonary system and pancreas exocrine
      function.

      Several studies showed that cystic fibrosis commonly induces a reduction of effort tolerance,
      peripheral muscular strength and work capacity.

      Patients suffering from cystic fibrosis with a high endurance capacity have a lower risk of
      poor prognosis. Those with a severe dyspnea have a higher benefit with a force training or a
      combined force and endurance training than with endurance training alone.

      We propose to study the effect of a quadriceps electrostimulation program, performed prior to
      an endurance retraining program using a cycloergometer, in patients with cystic fibrosis
      associated with severe pulmonary dysfunction, to enhance their muscular performance and
      increase their adherence to the cycloergometer retraining program.

      This is a randomized trial with two groups:

      Group A: experimental group, twenty patients. Six weeks with electrostimulation program
      followed by six weeks under a cycloergometer program.

      Group B: control group, twenty patients. Six weeks with their usual physical activity
      followed by six weeks with a cycloergometer program.

      The Randomization is stratified on expiratory volume per second. The size of randomization
      blocks is random because of the open design.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    enrolment difficulties
  </why_stopped>
  <start_date>October 2006</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The six-minute walking distance</measure>
    <time_frame>0, 1, 2 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cycloergometer test: maximum power, maximum oxygen consumption, minute ventilation</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inspiratory reserve volume (IRV), gasometry, dyspnea score</measure>
    <time_frame>0, 1, 2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of voluntary maximum force and non cooperative force of the quadriceps</measure>
    <time_frame>0, 1, 2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area of quadriceps cross section measured with a scanner</measure>
    <time_frame>1, 2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quadriceps muscle mass</measure>
    <time_frame>0, 1, 2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life: CFQ14, BDI-TDI questionnaires</measure>
    <time_frame>0, 1, 2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance with ergocycle rehabilitation</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HOMA and QUICKI tests</measure>
    <time_frame>0, 1, 2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spirometry</measure>
    <time_frame>0, 1, 2 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Cystic Fibrosis</condition>
  <condition>Mucoviscidosis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Quadriceps electrostimulation program, performed prior to an endurance retraining program using a cycloergometer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usual sport activity, performed prior to an endurance retraining program using a cycloergometer</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Electrostimulation programme: using a cycloergometer</intervention_name>
    <description>Quadriceps electrostimulation programme performed prior to an endurance retraining program using a cycloergometer, for 6 weeks, 60 to 90 minutes by session, 5 to 6 sessions per week</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Usual sport activity</intervention_name>
    <description>Usual sport activity performed prior to an endurance retraining program using a cycloergometer</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;= 18 years

          -  Patient suffering from cystic fibrosis

          -  Patient has at least three measures of maximum expiratory volume per second &lt;= 45% of
             the theory among the 6 last measures performed

          -  Affiliation to French social security

          -  Capacity to consent

        Exclusion Criteria:

          -  Pregnant women

          -  Contraindication to application of magnetic field

          -  Pacemaker

          -  History of neurosurgical intervention

          -  Presence of metallic particles near the stimulation site.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claire Cracowski, Dr</last_name>
    <role>Study Director</role>
    <affiliation>Pneumology Department of Grenoble University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pneumology Department of Grenoble University Hospital</name>
      <address>
        <city>Grenoble</city>
        <state>Isere</state>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pneumology Department of Lyon University Hospital</name>
      <address>
        <city>Lyon</city>
        <state>Rhone</state>
        <zip>69000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Pin I, Grenet D, Scheid P, Domblides P, Stern M, Hubert D. [Specific aspects and care of lung involvement in adults with cystic fibrosis]. Rev Mal Respir. 2000 Aug;17(3 Pt 2):758-78. Review. French.</citation>
    <PMID>11076386</PMID>
  </reference>
  <reference>
    <citation>de Meer K, Gulmans VA, van Der Laag J. Peripheral muscle weakness and exercise capacity in children with cystic fibrosis. Am J Respir Crit Care Med. 1999 Mar;159(3):748-54.</citation>
    <PMID>10051246</PMID>
  </reference>
  <reference>
    <citation>Selvadurai HC, Allen J, Sachinwalla T, Macauley J, Blimkie CJ, Van Asperen PP. Muscle function and resting energy expenditure in female athletes with cystic fibrosis. Am J Respir Crit Care Med. 2003 Dec 15;168(12):1476-80. Epub 2003 Sep 18.</citation>
    <PMID>14500260</PMID>
  </reference>
  <reference>
    <citation>Lands LC, Heigenhauser GJ, Jones NL. Respiratory and peripheral muscle function in cystic fibrosis. Am Rev Respir Dis. 1993 Apr;147(4):865-9.</citation>
    <PMID>8466121</PMID>
  </reference>
  <reference>
    <citation>Elkin SL, Williams L, Moore M, Hodson ME, Rutherford OM. Relationship of skeletal muscle mass, muscle strength and bone mineral density in adults with cystic fibrosis. Clin Sci (Lond). 2000 Oct;99(4):309-14.</citation>
    <PMID>10995596</PMID>
  </reference>
  <reference>
    <citation>de Meer K, Jeneson JA, Gulmans VA, van der Laag J, Berger R. Efficiency of oxidative work performance of skeletal muscle in patients with cystic fibrosis. Thorax. 1995 Sep;50(9):980-3.</citation>
    <PMID>8539680</PMID>
  </reference>
  <reference>
    <citation>Moser C, Tirakitsoontorn P, Nussbaum E, Newcomb R, Cooper DM. Muscle size and cardiorespiratory response to exercise in cystic fibrosis. Am J Respir Crit Care Med. 2000 Nov;162(5):1823-7.</citation>
    <PMID>11069820</PMID>
  </reference>
  <verification_date>November 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 23, 2006</study_first_submitted>
  <study_first_submitted_qc>October 23, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 24, 2006</study_first_posted>
  <last_update_submitted>November 10, 2010</last_update_submitted>
  <last_update_submitted_qc>November 10, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 11, 2010</last_update_posted>
  <responsible_party>
    <name_title>M. Eric Svahn</name_title>
    <organization>Clinical Research Department, Grenoble University Hospital</organization>
  </responsible_party>
  <keyword>Cystic fibrosis</keyword>
  <keyword>mucoviscidosis</keyword>
  <keyword>electrostimulation</keyword>
  <keyword>retraining</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Cystic Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

